Musk v. OpenAI trial opens with fraud claims dismissed

The Musk v. OpenAI trial is starting with a narrower case.

On April 24, the U.S. District Court for the Northern District of California deemed Elon Musk’s fraud and constructive fraud claims against OpenAI and Sam Altman dismissed with prejudice. The order says the trial will still proceed on breach of charitable trust and unjust enrichment claims.

Jury selection was scheduled for April 27, according to AP.

Why it matters

This case is not about a single ChatGPT feature. It is about OpenAI’s structure, mission, and control.

The dismissal removes two claims from the case, but it does not end the dispute over whether OpenAI’s shift from nonprofit research lab to capped-profit and then public-benefit AI company stayed consistent with its founding commitments.

The important distinction is scope. Fraud claims being dismissed with prejudice narrows what Musk can pursue in this case, but the remaining claims still leave the court examining whether OpenAI’s structure and conduct match its charitable commitments.

Tool impact

There is no immediate ChatGPT, Codex, or API product change.

The risk is governance overhang. Enterprise buyers and developers should watch for remedies, settlement terms, board constraints, or disclosures that could affect OpenAI’s operating model.

The practical buyer question is continuity. OpenAI remains one of the central AI platforms for chat, coding, APIs, and enterprise deployment. Any court-imposed governance changes, disclosures, or restructuring constraints could matter for long-term procurement even if models and products continue operating normally during the trial.

What to watch

The remaining claims matter because they keep the mission question in front of a jury.

Watch whether the trial produces internal documents about OpenAI’s Microsoft relationship, restructuring decisions, model access strategy, and how the company interprets “benefit all of humanity” in commercial deployment.

Also watch whether the dispute affects:

• OpenAI’s public-benefit conversion timeline
• board oversight and conflict-of-interest rules
• Microsoft commercial rights or strategic influence
• enterprise risk disclosures
• how OpenAI describes its mission in product and fundraising materials

Aipedia take

This is not a reason to stop using OpenAI tools. It is a reason to treat provider governance as part of AI vendor risk. For high-dependency teams, the safest posture is multi-provider architecture, clear data-export paths, and procurement notes that separate product capability from corporate-structure uncertainty.